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ABSTRACT
Background: Diagnostic testing is common during emergency department (ED) visits. Little is understood about
patient preferences for such testing. We hypothesized that a patient’s willingness to undergo diagnostic testing is
influenced by the potential benefit, risk, and personal cost.
Methods: We conducted a cross sectional survey among ED patients for diagnostic testing in two hypothetical
scenarios: chest pain (CP) and mild traumatic brain injury (mTBI). Each scenario defined specific risks, benefits,
and costs of testing. The odds of a participant desiring diagnostic testing were calculated using a series of
nested multivariable logistic regression models.
Results: Participants opted for diagnostic testing 68.2% of the time, including 69.7% of CP and 66.7% of all
mTBI scenarios. In the CP scenario, 81% of participants desired free testing versus 59% when it was associated
with a $100 copay (difference = 22%, 95% confidence interval [CI] = 16% to 28%). Similarly, in the mTBI
scenario, 73% of adult participants desired free testing versus 56% when charged a $100 copayment
(difference = 17%, 95% CI = 11% to 24%). Benefit and risk had mixed effects across the scenarios. In fully
adjusted models, the association between cost and desire for testing persisted in the CP (odds ratio [OR] = 0.33,
95% CI = 0.23 to 0.47) and adult mTBI (OR = 0.47, 95% CI = 0.33 to 0.67) scenarios.
Conclusions: In this ED-based study, patient preferences for diagnostic testing differed significantly across
levels of risk, benefit, and cost of diagnostic testing. Cost was the strongest and most consistent factor
associated with decreased desire for testing.
The emergency department (ED) has emerged as afocal point for rapid access to advanced diagnostic
testing and hospital admission. Currently, given the
pervasive nature of diagnostic testing in medical care,
there is increasing interest in reducing “low-value”
testing.1 Global definitions of low-value testing tend to
be subjective and difficult to apply to complex health
systems. In addition, evidence-based diagnostic testing
may allow for the best care at a population level, yet
may not be optimal for individual patients. Given this,
From the University of Michigan Medical School (JDP, APM, CM, RI), Ann Arbor, MI; the Department of Emergency Medicine, Maricopa Integrated
Health System (ESL), Phoenix, AZ; the Department of Population Health Sciences, University of Utah (AF), Salt Lake City, UT; the Department of
Veterans Affairs, Salt Lake City (AF), UT; and the Departments of Emergency Medicine and Neurology, University of Michigan Health System
(WJM), Ann Arbor, MI.
Received January 22, 2018; revision received February 20, 2018; accepted February 24, 2018.
This work presented at Society for Academic Emergency Medicine Annual Meeting, New Orleans, LA, May 2016.
This study was supported by the National Institutes of Health via grant 5T35HL007690-34 for salary support for JDP, CM, RI, and APM. In addi-
tion, ESL was supported via research funds from the University of Michigan Department of Emergency Medicine and the NIH via grant 5TL1
TR000435.
The authors have no potential conflicts to disclose.
Author contributions: JPD, APM, and WJM designed the study with JPD and APM collecting the data; AF provided study design and statistical
support; and all authors contributed to editing and preparing the final manuscript.
Supervising Editor: Michael S. Runyon, MD.
Address for correspondence and reprints: Dr. William J. Meurer, MD, MS; e-mail: wmeurer@umich.edu.
ACADEMIC EMERGENCY MEDICINE 2018;25:627–633.
© 2018 by the Society for Academic Emergency Medicine
doi: 10.1111/acem.13404
ISSN 1553-2712
627
taking patient preferences into account may help to
better tailor care for individuals.2
Health insurance has been evolving in the United
States with numerous recent policy changes. In gen-
eral, patients are being asked to pay a larger propor-
tion of their health care costs. Increasingly, clinicians
are encouraged to involve patients in discussions
regarding the value of health care options. Shared deci-
sion making potentially allows patient values, goals,
and preferences to be reflected in the decision to agree
to a diagnostic test. Currently, these discussions are
challenging as the costs and benefits of tests are often
difficult to define or even estimate.1,3
The current investigation aims to estimate the indi-
vidual level trade-offs between the benefits, risks, and
cost of a diagnostic test within hypothetical acute medi-
cal conditions commonly seen in an ED. We hypothe-
sized that a patient’s willingness to undergo a
diagnostic test is associated with different levels of
potential benefit, risk, and the out-of-pocket cost of
this test.
METHODS
Overview
This is a cross-sectional survey of the effect of varying
levels of risk, benefit, and cost of diagnostic testing on
the probability of agreeing to pursue testing in two
hypothetical clinical scenarios among adult patients in
the University of Michigan ED.
Study Design
Participants were presented with two hypothetical clini-
cal scenarios, in random order, in which they present
to the ED with either low-risk chest pain (CP) or mild
traumatic brain injury (mTBI). A subset of the mTBI
respondents with children under the age of 18 were
given a similar scenario in which their child was the
patient (mTBI-child) instead of themselves (mTBI-
adult).
Participants responded to both clinical scenarios
and were randomly assigned to scenarios that
described that risk as 0.1% or 1%, a benefit of 0.1%
or 1%, and a cost of $0 or $100 for the diagnostic
test. All eight combinations were given; in each, bene-
fit and risk could be equal or unequal. Different com-
binations of benefit, risk, and cost could be presented
to one individual for the CP and mTBI scenarios.
These values were chosen to maximize the sensitivity
of the study to detect differences in patient preferences
based on a preliminary study performed by the
authors, where we believed the most interesting zone
of variation in patients’ desire for diagnostic testing
was for risk and benefit levels of 0.1 and 1% and cost
levels of $0 and $100.4 Additionally, risk values of 0.1
and 1% were felt to represent a realistic chance of
developing cancer from diagnostic testing with
radiation.5 To improve participants’ incorporation of
numerical values into their decision making, patients
were presented with both textual and graphical repre-
sentations where risk and benefit values were pre-
sented as a ratio and percentage, as well as with a
pictograph representing values of 1 in 100 and 1 in
1000.6 No graphical representation of money was
employed.
A structured survey was then administered in which
participants were asked to decide if they would pursue
diagnostic testing given different levels of risk (the
development of cancer within 10 years due to ionizing
radiation from the test), benefit (the chance of having
an accurate diagnosis of disease requiring medical
intervention), and cost (an additional test-specific
copay) associated with the diagnostic test. Prior to
launch, we used this survey in a prior, online-only
study.4 In addition, we pilot tested the questions
among adults associated with the study team. The sur-
vey was read aloud to all patients to reduce any misun-
derstandings caused by difficulties with reading or
seeing. The full transcript of the scenarios and survey
is available in Data Supplement S1 (available as sup-
porting information in the online version of this
paper, which is available at http://onlinelibrary.wiley.c
om/doi/10.1111/acem.13404/full).
Setting and Participants
A convenience sample of adult patients who presented
to the University of Michigan ED during daytime
hours in June, July, and August 2015 were recruited
in the study until 900 completed surveys were
achieved. Patients presenting with CP or recent head
injury were not recruited so as to not interfere with
their clinical course. Additionally, patients who were
under contact precautions or in resuscitation bays
were not approached. No compensation was offered
for completion and participation was completely
voluntary.
Variables: Data Sources and Measurement
The primary outcome was the number of patients who
desired the diagnostic test in each of the two
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hypothetical scenarios. Risk, benefit, and cost of diag-
nostic testing were the main predictive variables.
Potential confounders included age; sex; race; ethnic-
ity; marital status; highest level of education; house-
hold income; if they were a medical professional; past
medical history of cancer, hypertension, diabetes, atrial
fibrillation, and myocardial infarction; and self-
reported overall health. We used a standardized data
collection form through Qualtrics (Data Supplement
S1).
Statistical Analysis
Study Size. We surveyed 900 patients to ensure
that we had at least 100 patients within each of the
eight study arms (from the 2 9 2 9 2 study arm with
two levels of the three key factors: risk, benefit, and
cost). For each of the major comparisons (i.e., cost $0
vs. $100), a total sample size of 900 provided approxi-
mately 86% power to detect a change in the propor-
tion choosing a test from 50% to 60% with an alpha
of 0.05. In addition, to ensure that our logistic regres-
sion model was not overparameterized, we limited the
fully adjusted model to 30 variables based on a pre-
dicted 300 outcome events (given a 33% event rate
from our prior work and 900 subjects in the current
study) and according to the guideline of 10 events per
predictor for construction of logistic regression
models.4,7 We did not have a formal main statistical
hypothesis and did not have a prespecified belief
regarding the relative importance of risk, benefit, and
cost.
Data Analysis. All administered surveys in which
the primary outcome was completed were analyzed.
The unadjusted proportion of respondents who
desired diagnostic testing for each level of risk, benefit,
and cost were compared for the CP and mTBI scenar-
ios. For proportions and differences in proportions,
95% confidence intervals (CIs) were calculated using
the normal approximation. A series of nested multi-
variable logistic regression models were then fit to pre-
dict the adjusted odds of desiring diagnostic testing for
the CP and mTBI scenarios. We present odds ratios
(ORs) along with 95% CIs for the predictors in the
models. We considered three sets of variables to adjust
for in the models, first simply examining cost, risk,
and benefit in a single model; second adding in demo-
graphic factors; and third adding in variables regarding
personal experience with health care. We specified all
of these sets of variables in advance based on our
belief on potential confounders from the perspective
of clinical experience and scientific plausibility. Model
1 provided estimates for the cost, benefit, and risk of
testing simultaneously. Model 2 included everything
from Model 1 and further adjusted for demographic
variables including age, sex, race, ethnicity, marital sta-
tus, education, and income. Model 3 included every-
thing from Model 2 and further adjusted for variables
associated with a participant’s experience with health
care decision making, including working in the medi-
cal or health field, personal history of cancer, high
blood pressure, diabetes, atrial fibrillation, and myocar-
dial infarction, as well as self-reported overall health
status. A subgroup analysis of respondents who were
asked to decide about diagnostic testing for their child
versus themselves in the mTBI scenario was con-
ducted using the same statistical techniques. As this
was an exploratory, observational study, no adjust-
ments for multiple comparisons were made.
RESULTS
Among the 928 patients who met inclusion criteria
and were administered the survey, 28 were excluded
for failure to complete the primary outcome portion of
the survey. Results from the remaining 900 patients
were included in the study and analysis. The mean
(SD) participant age was 46.4 (17.0) years. Addi-
tional participant characteristics reflect the demograph-
ics of a large suburban ED (Table 1).
Overall, participants elected to have diagnostic test-
ing 68.2% of the time, including 69.7% of CP and
66.7% of all mTBI scenarios. In the unadjusted analy-
sis (Table 2), increased cost and decreased benefit of
testing were associated with decreased desire for diag-
nostic testing among adults responding for themselves
in both CP and mTBI scenarios, although this did
not reach significance for test benefit in the mTBI-
adult scenario. For example, desired testing fell from
80.8% to 58.7% in the CP scenario when comparing
the free versus $100 testing situations; the absolute dif-
ference in proportions was 22% (95% CI = 16.1% to
27.7%); a similar magnitude drop of 17.4% (95%
CI = 10.5% to 24%) was observed in the mTBI-adult
scenario. The risk of diagnostic testing was not associ-
ated with desire for testing in either the CP or the
mTBI-adult scenarios. Among mTBI scenarios, par-
ents were significantly more likely to desire testing for
their children than themselves at almost all levels of
risk, benefit, and cost. This difference was most
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pronounced for higher-cost testing, which was desired
30.2% (95% CI = 17.8% to 38.6%) more often for
their children than for themselves, and least pro-
nounced for free testing, which was the only instance
where parents’ desire for testing of their children was
not significantly higher than for themselves (differ-
ence = 8.2%; 95% CI = –3.4% to 17.1%). Further-
more, parents’ desire for diagnostic testing of their
children was not significantly associated with risk, ben-
efit, or cost.
The pattern of desire for diagnostic testing in the
adjusted regression models was similar to the unad-
justed analysis, with increased cost and decreased ben-
efit being associated with decreased desire for
diagnostic testing among adults responding for them-
selves. Furthermore, there were no substantial changes
in the odds of the primary outcome after fully adjust-
ing for demographics and experience with medical
decisions (Table 3), suggesting that the relationship
between desire for diagnostic testing and the benefits,
risks, and cost of testing are not confounded these
variables.
In the fully adjusted models (Table 3), the odds of
an adult desiring diagnostic testing for him or herself
are lower when testing costs $100 compared to $0, for
both CP (adjusted OR [AOR] = 0.33 [95% CI = 0.23
to 0.47]) and adult mTBI (AOR = 0.47 [95% CI =
0.33 to 0.67]). In addition, we observed higher odds
of desired testing when the benefit of testing increased
from 0.1% to 1.0% for the CP scenarios: AOR =
1.67 (95% CI = 1.18 to 2.35). This did not reach sig-
nificance for test benefit in the mTBI-adult scenario.
The fully adjusted models of desire for testing in
each clinical scenario (Data Supplement S1, eTables
1–4) demonstrated that patients over the age of 65 are
significantly less likely to desire testing for CP com-
pared to patients less than 35 years old (AOR = 0.49;
95% CI = 0.25 to 0.94). College graduates are the
most likely to desire testing for both CP and mTBI,
and more than twice as likely than those with some
high school education (AOR = 2.12, 95% CI = 1.07
to 4.21). Participants who earned less than $25,000
per year were significantly less likely to desire testing
for CP (but not mTBI) than almost all other income
brackets, even after controlling for cost. Physicians,
pharmacists, and nurses are significantly less likely to
desire diagnostic testing for themselves when com-
pared to nonmedical professionals and other ancillary
medical staff when presented with the mTBI-adult sce-
nario but not the CP or the mTBI-child scenarios.
Table 1
Characteristics of Survey Participants (N = 900)
Characteristic No. (%)
Age, years (n = 898)
≤35 271 (30.2)
35–49 226 (25.2)
50–64 258 (28.7)
≥65 143 (15.9)
Male (n = 897) 449 (50.1)
Race (n = 892)
Caucasian 663 (74.3)
African American 150 (16.8)
Asian 46 (5.2)
Other 33 (3.7)
Hispanic (n = 890) 46 (5.2)
Marital status (n = 895)
Married 429 (47.9)
Single/never married 294 (32.9)
Previously married 172 (19.2)
Have children under 18 267 (29.7)
Highest level of education (n = 892)
Some high school 79 (8.9)
High school graduate 184 (20.6)
Some college 266 (29.8)
College graduate 252 (28.3)
Postgraduate 111 (12.4)
Household income level (n = 756)
Less than $25,000 267 (35.3)
$25,000–$49,999 171 (22.6)
$50,000–$74,999 113 (15)
$75,000–$99,999 62 (8.2)
$100,000–$149,000 91 (12)
$150,000 or more 52 (6.9)
Health care professional (n = 893)
No 659 (73.8)
Practitioner 72 (8.1)
Ancillary staff (not directly
involved in clinical
decision making)
162 (18.1)
Past medical history
History of cancer (n = 895) 162 (18.1)
History of diabetes
(n = 894)
167 (18.7)
History of hypertension
(n = 894)
298 (33.3)
History of atrial fibrillation
(n = 894)
64 (7.2)
History of heart attack
(n = 894)
47 (5.3)
Overall health (n = 893)
Poor 112 (12.5)
Fair 224 (25.1)
Good 298 (33.4)
Very good 203 (22.7)
Excellent 56 (6.3)
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DISCUSSION
This study evaluated the relationship between risk, ben-
efit, and cost of diagnostic testing on patient prefer-
ences for pursuing low-value testing the ED. In this
cross-sectional convenience sample, we found that the
cost and potential benefits of a radiologic diagnostic
test play an important role in patients’ preferences for
pursuing diagnostic testing. Interestingly, the risk of the
test was not significantly associated with the odds of
pursuing testing. This work is hypothesis generating.
Table 3
Associations Between Testing Risk, Benefit, and Cost: Logistic Regression Models
AOR (95% CI)
Model 1 Model 2 Model 3
CP (n = 900)
Risk (1% vs. 0.1%) 1.01 (0.75 to 1.36) 0.99 (0.71 to 1.39) 0.98 (0.70 to 1.38)
Benefit (1% vs. 0.1%) 1.55 (1.15 to 2.08) 1.63 (1.16 to 2.29) 1.67 (1.18 to 2.35)
Cost ($100 vs. $0) 0.34 (0.25 to 0.46) 0.34 (0.24 to 0.48) 0.33 (0.23 to 0.47)
mTBI-all (n = 900)
Risk (1% vs. 0.1%) 0.80 (0.60 to 1.06) 0.82 (0.60 to 1.13) 0.82 (0.60 to 1.14)
Benefit (1% vs. 0.1%) 1.30 (0.98 to 1.73) 1.24 (0.90 to 1.71) 1.27 (0.92 to 1.76)
Cost ($100 vs. $0) 0.50 (0.37 to 0.66) 0.53 (0.39 to 0.73) 0.50 (0.36 to 0.69)
mTBI-adult (n = 775)
Risk (1% vs. 0.1%) 0.86 (0.64 to 1.16) 0.87 (0.62 to 1.21) 0.86 (0.61 to 1.20)
Benefit (1% vs. 0.1%) 1.35 (0.999 to 1.82) 1.26 (0.90 to 1.77) 1.28 (0.90 to 1.80)
Cost ($100 vs. $0) 0.46 (0.34 to 0.62) 0.50 (0.36 to 0.71) 0.47 (0.33 to 0.67)
mTBI-child (n = 125)
Risk (1% vs. 0.1%) 0.48 (0.19 to 1.26) 0.51 (0.12 to 2.16) 1.75 (0.19 to 16.53)
Benefit (1% vs. 0.1%) 1.08 (0.40 to 2.94) 0.73 (0.16 to 3.44) 1.02 (0.07 to 16.00)
Cost ($100 vs. $0) 1.42 (0.52 to 3.85) 1.09 (0.26 to 4.49) 2.19 (0.20 to 23.42)
Nested logistic regression models of the odds of electing diagnostic testing among ED patients presented with hypothetical clinical sce-
narios of CP and mTBI. Model 1 accounts only for risk, benefit, and cost simultaneously. Model 2 adds demographic variables including
age, sex, race, ethnicity, marital status, education, and income. Model 3 additionally includes working in the medical or health field; per-
sonal history of cancer, high blood pressure, diabetes, atrial fibrillation, and myocardial infarction; as well as self-reported overall health
status.
AOR = adjusted odds ratio; CP = chest pain; mTBI = mild traumatic brain injury.
Table 2
Testing Preferences Across Varying Levels of Risk, Benefit, and Cost for Each Scenario
Number Desiring Testing/Number Randomized to Group (%) Difference Between
Percent Desiring Testing
Among mTBI-child and
mTBI-adult (95% CI)CP (n = 900) mTBI-adult (n = 775) mTBI-child (n = 125)
Risk
0.1% 319/453 (70.4) 249/380 (65.5) 63/72 (87.5) 22.0% (11.3% to 29.6%)
1% 308/447 (68.9) 247/395 (62.5) 41/53 (77.4) 14.8% (1.1% to 25.2%)
Diff. (95% CI) –1.5% (–7.5% to 4.5%) –3.0% (–9.7% to 3.8%) –10.1% (–24.3% to 3.1%)
Benefit
0.1% 291/448 (65.0) 228/375 (60.8) 59/72 (81.9) 21.1% (9.7% to 29.9%)
1% 336/452 (74.3) 268/400 (67.0) 45/53 (84.9) 17.9% (5.2% to 26.6%)
Diff. (95% CI) +9.4% (3.4% to 15.3%) +6.2% (–0.6% to 12.9%) +3.0% (–11.0% to 15.7%)
Cost
$0 361/447 (80.8) 275/377 (72.9) 56/69 (81.2) 8.2% (–3.4% to 17.1%)
$100 266/453 (58.7) 221/398 (55.5) 48/56 (85.7) 30.2% (17.8% to 38.6%)
Diff. (95% CI) –22.0% (–27.7% to –16.1%) –17.4% (–24.1% to –10.5%) +4.6% (–9.1% to 18.3%)
Total 627/900 (69.7) 496/775 (64.0) 104/125 (83.2)
Proportions are unadjusted.
CP = chest pain; diff. = difference; mTBI = mild traumatic brain injury.
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There are some potential implications of payers and
patients. An additional $100 patient required contribu-
tion to the testing tended to decrease desire for testing
from about 80% to about 60%. In addition, the impli-
cation for practicing emergency physicians is as follows
—increasing the risk of a diagnostic test did not seem
to diminish the patient desire for the test therefore dis-
cussion regarding testing that involve risk may not
influence patient desires, at least in the low probability
space of testing risk of 1% and less.
One explanation for why risk was not a significant fac-
tor could be that the difference between 0.1 and 1% repre-
sents an insignificant increase in risk to our respondents.
However, this same increase in benefit did show a signifi-
cant effect. Another possibility is that patients care more
about their immediate needs, such as the chance of find-
ing an underlying condition and how much it will cost
them, and less about the future risk of developing cancer.
Additionally, many patients may associate brain bleeds
and heart disease, but not necessarily cancer, with definite
or immediate mortality and morbidity. They may view the
presented scenario as a choice between the immediate risk
of certain death or disability against the possibility of a
treatable illness in the distant future.
Interestingly, patients appear to hold different values
regarding diagnostic testing for their children than they
hold for themselves. Those who were presented with
the mTBI scenario for their child pursued diagnostic
testing more frequently than for themselves regardless
of the level of benefit, risk, or cost. While this study
lacked the statistical power to draw major conclusions
about the pediatric scenario, further research may
uncover interesting results about how parents make
health care decisions for their children as opposed to
for themselves.
These relationships of benefit, risk, and cost were
not affected by any confounding factors that we mea-
sured. There were however some subgroups which
behaved slightly differently, but these did not affect the
overall results (Data Supplement S1, eTables 1–4).
Notably, health care providers desired testing less often
for the mTBI scenario but not the CP scenario. This
is likely explained by the decreased prevalence of
major intracranial bleeding in TBI patients with a
benign examination versus a reasonably high preva-
lence of coronary artery disease in the population of
patients with CP. Another interesting outlier is the
lowest income group (less than $25,000), which was
the only income subgroup that generally declined test-
ing, even when they were told it would be free to
them. This study was not designed to evaluate sub-
tleties between demographic groups but it is an inter-
esting finding nonetheless.
Increasing the cost of the diagnostic test from $0 to
$100 was associated with a threefold decreased odds of
pursuing diagnostic testing. This implies that the cost
of care is a major factor patients consider and may be
used to discourage low-value testing through test-speci-
fic copayments, although this may also discourage rea-
sonable testing as well. Medicare reimbursements are
increasingly becoming tied to patient satisfaction,
which is associated with patients receiving the tests they
believe they need.8,9 Further investigations could
explore whether individual financial incentives prevent
low-risk patients from seeking wasteful testing to the
same degree as charging patients a fee for the test.
There are a few key limitations to consider when
interpreting the results of our study. First, this study
asked participants to imagine a hypothetical situation
that is subject to limitations of imagination. It is likely
more difficult for patients to consider the distant risk
of developing cancer when also contemplating a poten-
tial myocardial infarction or brain hemorrhage. This
reflects the well-known human behavior of time dis-
counting. Second, respondents may have had difficulty
fully embracing the risks and benefits that were given
to them, largely since they had difficulty believing their
own real-life comorbidities and risk factors were prop-
erly accounted for in the scenario despite the design
emphasizing they were. As an example, some patients
on anticoagulation have been instructed to always get a
head CT scan if they fall and they may have been
assigned to the 0.1% risk category in our study. Third,
many patients may also have struggled with interpreting
percentages, despite the use of visual aids. Fourth, this
study limits the risk of a test to the probability of devel-
oping cancer in the future secondary to radiation and
this is an oversimplification of a very complex issue. In
reality, the risks of diagnostic tests are highly variable,
and assessing their numerical risk is challenging. The
scenarios we utilized were emergent situations, and
they helped expose patients’ underlying values regard-
ing the risks, benefits, and costs of diagnostic testing.
While these findings could theoretically be generalized
to other situations of risk, benefit, and cost, our study
was specifically restricted to low-benefit and low-risk sit-
uations regarding diagnostic radiologic testing in the
ED. The above relationships may vary significantly in
different contexts or at different levels of benefit, risk,
and cost. Next, the mTBI-child group was
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underpowered to demonstrate any associations between
risk, benefit, and cost with desire for diagnostic testing.
Fifth, we did not assess numeracy using a validated
scale, but instead used pictographs—a method consid-
ered to be one of the best methods of communication
for those with low numeracy.10 Sixth, the patient was
not experiencing the acute uncertainty and potential
anxiety of CP or a head injury and as such willingness
to undergo testing may be different. Finally, this study
did not utilize a true shared decision-making model
where the physician and the patient discuss the risks
and benefits and then make a choice together. Rather,
this study assumed the physician could calculate the
risk and benefit with 100% accuracy and then forced
the patient to decide on their own in essentially a
reverse paternalistic model. Future work could consider
adding in provider uncertainty regarding benefits and
risks possibly by adding ranges (i.e., “your risk of a
brain bleed is between 1 in 1000 and 1 in 10,000”)
with pictographic supporting materials.
CONCLUSIONS
This cross-sectional survey suggests that patient prefer-
ences for diagnostic testing differ based on the cost and
benefits of testing, but that long-term risks may play a
smaller role. Additionally, finances seemed to be a
major motivating factor for patients to avoid testing.
With patients having a growing personal contribution
to health care, this impact should be studied further to
determine how best to implement financial considera-
tions to alter testing behavior. This study utilized a
copay to “penalize” for the test; however, a credit for
foregoing the test similar to a safe driver discount would
be an interesting direction for future research.
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